Reaktion #44874

ord-0f9e13c6d3304deea6cdd84e880c7264

Reaktionsgleichung

CC(C)n1c(=O)n(C(=O)NCC2CCNCC2)c2ccccc21
3-isopropyl-2-oxo-N-(piperidin-4-ylmethyl)-2,3-dihydro-1H-benzimidazole-1-carboxamide
CC(C)n1c(=O)n(C(=O)NCC2CCNCC2)c2ccccc21
3-Isopropyl-2-oxo-N-(piperidin-4-ylmethyl)-2,3-dihydro-1H -benzimidazole-1-carboxamide
C=CC(=O)OC(C)(C)C
tert-butyl acrylate
CC(C)n1c(=O)n(C(=O)NCC2CCN(CCC(=O)OC(C)(C)C)CC2)c2ccccc21
title compound
Ausbeute 16.0%
CC(C)n1c(=O)n(C(=O)NCC2CCN(CCC(=O)OC(C)(C)C)CC2)c2ccccc21
tert-butyl 3-[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H -benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]propanoate
Ausbeute 16.0%

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Temperaturwas refluxed for 18 h
  2. 2
    TemperaturAfter cooling
  3. 3
    Extraktionextracted with CH2Cl2 (100 mL) for three times
  4. 4
    TrocknenThe combined extracts were dried over Na2SO4
  5. 5
    Filtrationfiltered
  6. 6
    Einengenconcentrated
  7. 7
    SonstigeThe residue was chromatographed on a column of silica gel
  8. 8
    Wascheneluted with MeOH/CH2Cl2 (1:20→1:10)
  9. 9
    WaschenNH-silica gel eluted with EtOAc/hexane (1:5→1:2)

Vorschrift

A mixture of 3-isopropyl-2-oxo-N-(piperidin-4-ylmethyl)-2,3-dihydro-1H-benzimidazole-1-carboxamide (0.50 g, 1.58 mmol, Step 2), tert-butyl acrylate (0.340 mL, 2.37 mmol) and iPrNEt (0.275 mL, 2.37 mmol) in THF (20 mL) was refluxed for 18 h. After cooling, the reaction mixture was diluted with sat. NaHCO3 aq. (100 mL), extracted with CH2Cl2 (100 mL) for three times. The combined extracts were dried over Na2SO4, filtered and concentrated. The residue was chromatographed on a column of silica gel eluted with MeOH/CH2Cl2 (1:20→1:10) and then NH-silica gel eluted with EtOAc/hexane (1:5→1:2) to give 0.111 g (16%) of title compound as colorless syrup.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07737163B2uspto-grants-2010_06